Legis Daily

United States Anti-Doping Agency Reauthorization Act of 2021

USA117th CongressHR-172| House 
| Updated: 4/15/2021
Mike Thompson

Mike Thompson

Democratic Representative

California

Cosponsors (2)
Diana DeGette (Democratic)Bill Johnson (Republican)

Commerce, Science, and Transportation Committee, Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
United States Anti-Doping Agency Reauthorization Act of 2021 This bill authorizes appropriations for the U.S. Anti-Doping Agency (USADA) through FY2030. The bill adds requirements that USADA be responsible for certifying in advance any testing conducted by international organizations under the World Anti-Doping Code for international amateur athletes and athletic competitions occurring within the jurisdiction of the United States; and promote a positive youth sport experience by using a portion of its funding to provide educational materials on sportsmanship, character building, and healthy performance for those participating in youth sports. The bill requires any action taken by USADA to enforce a policy, procedure, or requirement against a person with respect to a violation of federal law, including an investigation, disciplinary action, sanction, or any other administrative action, to be carried out in a manner that provides due process protection. The Department of Justice, the Department of Homeland Security, and the Food and Drug Administration must provide to USADA information relating to the prevention of the use of performance-enhancing drugs or the prohibition of performance-enhancing methods.

Bill Text Versions

View Text
3 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-5373
United States Anti-Doping Agency Reauthorization Act of 2020
Jan 4, 2021
Introduced in House
Jan 4, 2021
Referred to the House Committee on Energy and Commerce.
Feb 2, 2021
Referred to the Subcommittee on Health.
Mar 3, 2021

Latest Companion Bill Action

S 117-585
Introduced in Senate
Apr 14, 2021
Mr. Pallone moved to suspend the rules and pass the bill.
Apr 14, 2021
Considered under suspension of the rules. (consideration: CR H1748-1750)
Apr 14, 2021
DEBATE - The House proceeded with forty minutes of debate on H.R. 172.
Apr 14, 2021
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Apr 14, 2021
Considered as unfinished business. (consideration: CR H1781-1782)
Apr 14, 2021
On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 381 - 37 (Roll no. 99). (text: CR H1748)
View Vote
Apr 14, 2021
Motion to reconsider laid on the table Agreed to without objection.
Apr 15, 2021
Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.
  • Bill from Previous Congress

    HR 116-5373
    United States Anti-Doping Agency Reauthorization Act of 2020


  • January 4, 2021
    Introduced in House


  • January 4, 2021
    Referred to the House Committee on Energy and Commerce.


  • February 2, 2021
    Referred to the Subcommittee on Health.


  • March 3, 2021

    Latest Companion Bill Action

    S 117-585
    Introduced in Senate


  • April 14, 2021
    Mr. Pallone moved to suspend the rules and pass the bill.


  • April 14, 2021
    Considered under suspension of the rules. (consideration: CR H1748-1750)


  • April 14, 2021
    DEBATE - The House proceeded with forty minutes of debate on H.R. 172.


  • April 14, 2021
    At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.


  • April 14, 2021
    Considered as unfinished business. (consideration: CR H1781-1782)


  • April 14, 2021
    On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 381 - 37 (Roll no. 99). (text: CR H1748)
    View Vote


  • April 14, 2021
    Motion to reconsider laid on the table Agreed to without objection.


  • April 15, 2021
    Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.

Sports and Recreation

Related Bills

  • HR 117-2471: Consolidated Appropriations Act, 2022
  • S 117-585: United States Anti-Doping Agency Reauthorization Act of 2021
Alternative dispute resolution, mediation, arbitrationAthletesChild healthCongressional oversightCriminal investigation, prosecution, interrogationDrug, alcohol, tobacco useDrug safety, medical device, and laboratory regulationDue process and equal protectionInternational law and treatiesInternational organizations and cooperationMedical tests and diagnostic methodsOlympic games

United States Anti-Doping Agency Reauthorization Act of 2021

USA117th CongressHR-172| House 
| Updated: 4/15/2021
United States Anti-Doping Agency Reauthorization Act of 2021 This bill authorizes appropriations for the U.S. Anti-Doping Agency (USADA) through FY2030. The bill adds requirements that USADA be responsible for certifying in advance any testing conducted by international organizations under the World Anti-Doping Code for international amateur athletes and athletic competitions occurring within the jurisdiction of the United States; and promote a positive youth sport experience by using a portion of its funding to provide educational materials on sportsmanship, character building, and healthy performance for those participating in youth sports. The bill requires any action taken by USADA to enforce a policy, procedure, or requirement against a person with respect to a violation of federal law, including an investigation, disciplinary action, sanction, or any other administrative action, to be carried out in a manner that provides due process protection. The Department of Justice, the Department of Homeland Security, and the Food and Drug Administration must provide to USADA information relating to the prevention of the use of performance-enhancing drugs or the prohibition of performance-enhancing methods.

Bill Text Versions

View Text
3 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-5373
United States Anti-Doping Agency Reauthorization Act of 2020
Jan 4, 2021
Introduced in House
Jan 4, 2021
Referred to the House Committee on Energy and Commerce.
Feb 2, 2021
Referred to the Subcommittee on Health.
Mar 3, 2021

Latest Companion Bill Action

S 117-585
Introduced in Senate
Apr 14, 2021
Mr. Pallone moved to suspend the rules and pass the bill.
Apr 14, 2021
Considered under suspension of the rules. (consideration: CR H1748-1750)
Apr 14, 2021
DEBATE - The House proceeded with forty minutes of debate on H.R. 172.
Apr 14, 2021
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Apr 14, 2021
Considered as unfinished business. (consideration: CR H1781-1782)
Apr 14, 2021
On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 381 - 37 (Roll no. 99). (text: CR H1748)
View Vote
Apr 14, 2021
Motion to reconsider laid on the table Agreed to without objection.
Apr 15, 2021
Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.
  • Bill from Previous Congress

    HR 116-5373
    United States Anti-Doping Agency Reauthorization Act of 2020


  • January 4, 2021
    Introduced in House


  • January 4, 2021
    Referred to the House Committee on Energy and Commerce.


  • February 2, 2021
    Referred to the Subcommittee on Health.


  • March 3, 2021

    Latest Companion Bill Action

    S 117-585
    Introduced in Senate


  • April 14, 2021
    Mr. Pallone moved to suspend the rules and pass the bill.


  • April 14, 2021
    Considered under suspension of the rules. (consideration: CR H1748-1750)


  • April 14, 2021
    DEBATE - The House proceeded with forty minutes of debate on H.R. 172.


  • April 14, 2021
    At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.


  • April 14, 2021
    Considered as unfinished business. (consideration: CR H1781-1782)


  • April 14, 2021
    On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 381 - 37 (Roll no. 99). (text: CR H1748)
    View Vote


  • April 14, 2021
    Motion to reconsider laid on the table Agreed to without objection.


  • April 15, 2021
    Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.
Mike Thompson

Mike Thompson

Democratic Representative

California

Cosponsors (2)
Diana DeGette (Democratic)Bill Johnson (Republican)

Commerce, Science, and Transportation Committee, Health Subcommittee, Energy and Commerce Committee

Sports and Recreation

Related Bills

  • HR 117-2471: Consolidated Appropriations Act, 2022
  • S 117-585: United States Anti-Doping Agency Reauthorization Act of 2021
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Alternative dispute resolution, mediation, arbitrationAthletesChild healthCongressional oversightCriminal investigation, prosecution, interrogationDrug, alcohol, tobacco useDrug safety, medical device, and laboratory regulationDue process and equal protectionInternational law and treatiesInternational organizations and cooperationMedical tests and diagnostic methodsOlympic games